glp-1 injections kenner Weight Loss glp-1 weight loss kenner Woman,

Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide

As GLP1 use rises, new patient volume for hypertension and cholesterol therapies has declined, while GERD treatments remain stable due to GLP1s mixed impact, showing ripple effects across multiple disease areas

GLP-1 agonists like semaglutide and tirzepatide are groundbreaking for weight loss

Mounjaro is a newer option that targets two hormones and can be discussed with healthcare providers for suitable treatment plans

That stability lines up with recent analyst debate around Q4 results, the updated 2026 outlook, and the role of LifeMD's GLP-1 focused virtual care program in shaping long term expectations